Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Dermatology · Folliculitis Decalvans

Folliculitis Decalvans: When to Repeat Biopsy or Culture?

At a Glance

Not all folliculitis decalvans flares require repeat testing. Doctors may consider a biopsy when treatment fails, findings are unclear, or symptoms change, and a culture for severe or unresponsive relapses. Biopsy active edges and culture fresh drainage before a new antibiotic when possible.

Living with the repeated flares of folliculitis decalvans (FD) can be frustrating. Because FD is a chronic condition, not every new flare requires a repeat scalp biopsy or bacterial culture [1][2]. However, repeat testing may be considered if your symptoms do not respond to prescribed treatments, if there is a disagreement between how your scalp looks and your previous pathology results, or if you develop new, unusual symptoms [3][4]. Your doctor will individualize the decision based on how your condition is behaving, so it is helpful to bring a medication list, dates of recent antibiotics, and photographs of your flares to your appointments.

When to Consider a Repeat Scalp Biopsy

A scalp biopsy is a procedure where a small piece of skin is removed and examined under a microscope (pathology) [5]. This procedure is typically done under local anesthetic, may require a small stitch, and can leave a tiny scar. While a single biopsy is often enough to diagnose classic FD, a repeat biopsy may be useful in the following situations:

  • Persistent Activity Despite Treatment: If your condition continues to worsen despite taking treatments exactly as prescribed, a repeat biopsy can help confirm if another condition is mimicking FD [6][7].
  • Possible FD-LPP Overlap: Sometimes, FD can occur at the same time as another scarring hair loss condition called lichen planopilaris (LPP) [8][7][9]. If your doctor notices new signs like scaly skin around the hair follicles, a repeat biopsy can help identify this overlap, which may require a different treatment approach [10][7].
  • Disagreement Between Clinical Signs and Pathology: The inflammation in FD can be patchy, and a biopsy might sometimes miss the characteristic features (like a high number of white blood cells called neutrophils) [11][12][13]. If your scalp looks like FD but your first biopsy was inconclusive, a repeat biopsy may be necessary [3][4].
  • New Red-Flag Features: If you develop a rapidly growing lump, a non-healing ulcer, persistent bleeding, or an unusually painful nodule, you should seek prompt in-person evaluation by a dermatologist. Squamous cell carcinoma (a type of skin cancer) has rarely been reported in long-standing areas of scarring alopecia, including FD [14][15][16]. If malignancy is suspected, the suspicious lesion itself must be assessed and sampled.

Where should the repeat biopsy be taken?

To get the most accurate results for diagnosing FD or LPP, a biopsy should target an active edge—an area where the inflammation or hair loss is currently spreading [17][11]. Biopsying the center of an old, scarred area (end-stage lesion) often provides little information because the inflammation has already burned out [17][5]. Your doctor may use a specialized magnifying tool called a dermatoscope (trichoscopy) to closely examine your scalp and select the best active site [11][5]. In some cases, clinicians may take more than one punch biopsy or request specific sectioning methods from the lab to get a full view of the hair follicles [12][11].

When to Consider a Repeat Bacterial Culture

A bacterial culture involves a clinician taking a swab of the pus or crusts on your scalp to see what type of bacteria is growing and which anti-bacterial medications might work best against it.

  • Treatment Failure: A culture may be considered if your condition does not improve with standard antibiotics targeting Staphylococcus aureus, the most common bacteria involved in FD [2]. For example, one clinical study found that some patients who do not respond to standard treatments may have a gram-negative bacterial infection [18]. This finding may lead your clinician to consider a different type of antibiotic if the culture and susceptibility results support it.
  • Severe Relapses: If you experience a severe flare, a new culture may help identify currently recoverable organisms and guide susceptibility-based treatment [7]. Keep in mind that a positive culture just shows what is growing on the surface—which could be normal bacteria living on the skin (colonization)—and does not automatically prove bacteria are the sole cause of the flare.

How to get the most accurate culture results

For the best results, a culture should be taken by a clinician from a fresh, draining pustule or a hemorrhagic crust (a crust with blood and pus) [7][5]. Ideally, this sample is taken before you start a new course of antibiotics, because medications can hide the presence of bacteria and result in a false-negative (showing no bacteria when there actually is) [19].

Important Safety Note: Do not stop, delay, or interrupt your currently prescribed treatments without your doctor’s explicit instructions in order to get a culture.

Comparing Biopsy and Culture

Feature Scalp Biopsy Bacterial Culture
Purpose Examines skin tissue to confirm the diagnosis or identify an overlap condition like LPP. Swabs pus or crusts to identify bacteria and see which antibiotics might work against them.
How it is done A small piece of skin is removed (usually requiring local anesthetic and a stitch). A sterile swab is rubbed over a fresh pustule or draining crust by a clinician.
Best time/place Taken from an “active edge” of inflammation or hair loss. Taken from a fresh pustule, ideally before starting a new antibiotic.

Common questions in this guide

When might I need another scalp biopsy for folliculitis decalvans?
A repeat biopsy may be considered if your scalp worsens despite taking treatment as prescribed, your first biopsy was inconclusive, or the examination does not match the earlier result. It may also help check for lichen planopilaris overlap or assess a new suspicious lesion.
Where is the best place to take a repeat folliculitis decalvans biopsy?
The sample is usually taken from an active edge, where inflammation or hair loss is currently spreading, rather than the center of an old scar. A dermatologist may use a magnifying scalp exam to choose the site and may take more than one small sample.
When should a bacterial culture be repeated during an FD flare?
A clinician may consider a new culture when a flare is severe or does not improve with usual antibiotics. The result can identify bacteria and show which antibiotics may work best, but bacteria found on the scalp may simply be surface colonization and may not be the only cause of the flare.
How should a culture sample be collected for the most accurate result?
A clinician should swab a fresh draining pustule or a crust containing blood and pus, ideally before starting a new antibiotic. Do not stop, delay, or interrupt a current treatment unless your doctor specifically tells you to.
What scalp changes need prompt evaluation?
A rapidly growing lump, non-healing ulcer, persistent bleeding, or unusually painful nodule should be checked promptly in person by a dermatologist. Rarely, squamous cell carcinoma, a type of skin cancer, has been reported in long-standing scarring alopecia, so a suspicious lesion may need its own biopsy.

Get notified when new evidence is published on Quinquaud folliculitis decalvans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Management of folliculitis decalvans: The EADV task force on hair diseases position statement.

    Waśkiel-Burnat A, Starace M, Iorizzo M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.

    PMID: 40230058
  2. 2

    Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.

    Lyakhovitsky A, Segal O, Galili E, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(12)):1469-1477 doi:10.1111/ddg.15202.

    PMID: 37875786
  3. 3

    Linear Circumscribed Scleroderma-Like Folliculitis Decalvans: Yet Another Face of a Protean Condition.

    Rezende HD, Dias MFRG, Kempf W, Treüb RM

    International journal of trichology 2018; (10(4)):175-179 doi:10.4103/ijt.ijt_9_18.

    PMID: 30386078
  4. 4

    Clinico-Pathological Concordance Rate of Scalp Lesions Showing Alopecia.

    Jeong SH, Oh DY, Kim KJ, et al.

    Indian journal of dermatology 2022; (67(4)):324-327 doi:10.4103/ijd.ijd_112_22.

    PMID: 36578761
  5. 5

    Scalp Biopsies for Alopecia.

    Brunetti T, Misciali C, Rapparini L, et al.

    Dermatopathology (Basel, Switzerland) 2026; (13(3)) doi:10.3390/dermatopathology13030044.

    PMID: 42782841
  6. 6

    Lichen Planopilaris with Pustules: A Diagnostic Challenge.

    Morais KL, Martins CF, Anzai A, et al.

    Skin appendage disorders 2018; (4(2)):61-66 doi:10.1159/000478268.

    PMID: 29765960
  7. 7

    Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum-A Series of 7 New Cases With Focus on Histopathology.

    Egger A, Stojadinovic O, Miteva M

    The American Journal of dermatopathology 2020; (42(3)):173-177 doi:10.1097/DAD.0000000000001595.

    PMID: 31855586
  8. 8

    Folliculitis decalvans and lichen planopilaris phenotypic spectrum: a case series of biphasic clinical presentation and theories on pathogenesis.

    Yip L, Barrett TH, Harries MJ

    Clinical and experimental dermatology 2020; (45(1)):63-72 doi:10.1111/ced.13989.

    PMID: 31017678
  9. 9

    Clinical Characterization and Treatment Response of Folliculitis Decalvans Lichen Planopilaris Phenotypic Spectrum: A Unicentre Retrospective Series of 31 Patients.

    Melián-Olivera A, Moreno-Arrones Ó, Burgos-Blasco P, et al.

    Acta dermato-venereologica 2024; (104()):adv12373 doi:10.2340/actadv.v104.12373.

    PMID: 38372472
  10. 10

    Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.

    Pimenta R, Borges-Costa J

    Acta dermatovenerologica Croatica : ADC 2019; (27(1)):49-50.

    PMID: 31032795
  11. 11

    Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series.

    Uchiyama M, Harada K, Tobita R, et al.

    Journal of the American Academy of Dermatology 2021; (85(5)):1185-1193 doi:10.1016/j.jaad.2020.03.092.

    PMID: 32272176
  12. 12

    Compound Follicles in Folliculitis Decalvans Do Not Contain Vellus and Retained Telogen Follicles-A Pilot Histopathologic Series on Polytrichia.

    Lee J, Miteva M

    Journal of cutaneous pathology 2025; (52(1)):29-32 doi:10.1111/cup.14735.

    PMID: 39435542
  13. 13

    Epidermal psoriasiform hyperplasia, an unrecognized sign of folliculitis decalvans: A histological study of 26 patients.

    Matard B, Cavelier-Balloy B, Reygagne P

    Journal of cutaneous pathology 2017; (44(4)):352-357 doi:10.1111/cup.12892.

    PMID: 28067422
  14. 14

    Giant cutaneous squamous cell carcinoma of the scalp arising in the setting of folliculitis decalvans.

    Ding L, DeGiovanni JC, Bogner P, Soofi Y

    BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2021-247932.

    PMID: 35260404
  15. 15

    Metastatic squamous cell carcinoma arising in the setting of folliculitis decalvans.

    Esaa F, Shah PR, Dolohanty LB

    Dermatology online journal 2019; (25(4)).

    PMID: 31046918
  16. 16

    Squamous cell carcinoma originating in folliculitis decalvans.

    Luu Y, Kimmis BD, Pulumati A, et al.

    Dermatology online journal 2025; (31(1)) doi:10.5070/D331164986.

    PMID: 40526940
  17. 17

    Cross-sectional study to evaluate the utility of elastic tissue staining in primary cicatricial alopecia.

    Vishwanath T, Dhurat R

    Journal of clinical pathology 2024; (77(11)):737-742 doi:10.1136/jcp-2022-208745.

    PMID: 37553248
  18. 18

    Gram-negative infections in patients with folliculitis decalvans: a subset of patients requiring alternative treatment.

    Samrao A, Mirmirani P

    Dermatology online journal 2020; (26(2)).

    PMID: 32239885
  19. 19

    Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota.

    Matard B, Donay JL, Resche-Rigon M, et al.

    Experimental dermatology 2020; (29(3)):295-298 doi:10.1111/exd.13916.

    PMID: 30907453

This page explains when clinicians may consider repeat scalp testing for folliculitis decalvans for informational purposes only and does not constitute medical advice. Do not stop, delay, or change prescribed treatment without your dermatologist’s instructions.